Transphorm (NASDAQ:TGAN), a company valued at $151 million, is largely under the control of private equity firms which collectively hold a 48% stake, thereby having significant influence over key decisions. The largest shareholders, namely Kohlberg Kravis Roberts & Co. L.P., Aigh Capital Management, LLC, and Doris Hsu collectively own 55% of the company, indicating their considerable sway over its strategic direction.
Institutional investors hold a 16% stake in Transphorm, exposing them to 'crowded trade' risk during unfavorable trades. Insider holdings account for $13 million of the company's value, suggesting alignment between shareholders and the board while also highlighting potential power concentration.
The general public holds a 16% stake in Transphorm, representing a collective ability to impact company policies. Private equity firms, with their substantial ownership, can influence key policy decisions and encourage strategies to enhance market value.
Public companies have an 11% stake in Transphorm. This suggests strategic interest or de-merged business interests that warrant further scrutiny.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.